CHRS logo

Coherus BioSciences (CHRS) Selling, General & Administrative Expenses

Annual SGA

$192.01 M
-$6.47 M-3.26%

December 31, 2023

Summary

Performance

1-Year Change

-3.26%

3-Year Change

+38.06%

5-Year Change

+103.89%

15-Year Change

+169.29%

CHRS SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.5%
CHRS annual SGA is higher than 82.5% of companies in Healthcare sector

High & Low

All-time High

$198.48 M
CHRS annual SGA is currently -3.26% below its historical high of $198.48 million

3-Year Low

$169.71 M
CHRS annual SGA is currently +13.14% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CHRS previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 13, 2025
CHRS next annual earnings announcement is scheduled for Mar 13, 2025

OtherCHRSexpensesmetrics:

Annual Total Expenses

$460.44 M
CHRS annual total expenses is $460.44 million

Annual Operating Expenses

$301.45 M
CHRS annual total operating expenses is $301.45 million

Annual Cost Of Goods Sold

$158.99 M
CHRS annual cost of goods sold is $158.99 million

Annual Interest Expense

$40.54 M
CHRS annual interest expense is $40.54 million

Quarterly SGA

$34.74 M
-$421.00 K-1.20%

September 30, 2024

Summary

Performance

3-Month Change

-1.2%

1-Year Change

-27.95%

3-Year Change

-23.04%

5-Year Change

-23.04%

CHRS Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

75.49%
CHRS quarterly SGA is higher than 75.49% of companies in Healthcare sector

High & Low

All-time High

$56.53 M
CHRS quarterly SGA is currently -38.54% below its historical high of $56.53 million

3-Year Low

$34.74 M
CHRS quarterly SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CHRS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
CHRS next earnings announcement is scheduled for Mar 13, 2025

OtherCHRSexpensesmetrics:

Quarterly Total Expenses

$77.16 M
CHRS quarterly total expenses is $77.16 million

Quarterly Operating Expenses

$56.42 M
CHRS quarterly total operating expenses is $56.42 million

Quarterly Cost Of Goods Sold

$20.74 M
CHRS quarterly cost of goods sold is $20.74 million

Quarterly Interest Expense

$5.36 M
CHRS quarterly interest expense is $5.36 million

TTM SGA

-$6.05 B
-$450.00 K-0.01%

September 30, 2024

Summary

Performance

3-Month Change

-3291.92%

1-Year Change

-3182.44%

3-Year Change

-3236.71%

5-Year Change

-3236.71%

CHRS TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

5.68%
CHRS TTM SGA is higher than 5.68% of companies in Healthcare sector

High & Low

All-time High

-$99.59 M

3-Year Low

-$6.05 B
CHRS TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CHRS previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
CHRS next earnings announcement is scheduled for Mar 13, 2025

OtherCHRSexpensesmetrics:

Annual Total Expenses

$460.44 M
CHRS annual total expenses is $460.44 million

Annual Operating Expenses

$301.45 M
CHRS annual total operating expenses is $301.45 million

TTM Cost Of Goods Sold

$168.26 M
CHRS TTM cost of goods sold is $168.26 million

TTM Interest Expense

$32.43 M
CHRS TTM interest expense is $32.43 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$192.01 M
CHRS annual SGA is $192.01 million

Annual Operating Expenses

$301.45 M
CHRS annual total operating expenses is $301.45 million

Annual Cost Of Goods Sold

$158.99 M
CHRS annual cost of goods sold is $158.99 million

CHRS Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-3.3%-27.9%-3182.4%
3 y3 years+38.1%-23.0%-3236.7%
5 y5 years+103.9%-23.0%-3236.7%

CHRS Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-3.3%+13.1%-38.5%at low-52.9%at low
5 y5-year-3.3%+40.1%-38.5%+8.6%-89.2%at low
alltimeall time-3.3%+3371.6%-38.5%+1375.3%-5970.7%at low

Coherus BioSciences Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$34.74 M(-1.2%)
$175.94 M(-7.1%)
Jun 2024
-
$35.16 M(-37.8%)
$189.41 M(-5.0%)
Mar 2024
-
$56.53 M(+14.2%)
$199.39 M(+3.8%)
Dec 2023
$192.01 M(-3.3%)
$49.49 M(+2.6%)
$192.01 M(-2.1%)
Sep 2023
-
$48.22 M(+6.8%)
$196.14 M(+1.8%)
Jun 2023
-
$45.14 M(-8.2%)
$192.75 M(-3.1%)
Mar 2023
-
$49.15 M(-8.3%)
$198.88 M(+0.2%)
Dec 2022
$198.48 M(+17.0%)
$53.62 M(+19.6%)
$198.48 M(+1.8%)
Sep 2022
-
$44.83 M(-12.6%)
$194.91 M(+2.6%)
Jun 2022
-
$51.28 M(+5.2%)
$190.01 M(+6.1%)
Mar 2022
-
$48.75 M(-2.6%)
$179.07 M(+5.5%)
Dec 2021
$169.71 M(+22.0%)
$50.05 M(+25.4%)
$169.71 M(+7.9%)
Sep 2021
-
$39.92 M(-1.0%)
$157.35 M(+5.3%)
Jun 2021
-
$40.34 M(+2.4%)
$149.41 M(+4.4%)
Mar 2021
-
$39.39 M(+4.5%)
$143.12 M(+2.9%)
Dec 2020
$139.08 M(+1.5%)
$37.69 M(+17.8%)
$139.08 M(+1.2%)
Sep 2020
-
$31.98 M(-6.1%)
$137.46 M(+0.1%)
Jun 2020
-
$34.05 M(-3.7%)
$137.30 M(-1.7%)
Mar 2020
-
$35.35 M(-2.0%)
$139.70 M(+1.9%)
Dec 2019
$137.04 M(+45.5%)
$36.07 M(+13.3%)
$137.04 M(+1.7%)
Sep 2019
-
$31.83 M(-12.7%)
$134.81 M(+5.0%)
Jun 2019
-
$36.46 M(+11.5%)
$128.35 M(+16.4%)
Mar 2019
-
$32.68 M(-3.4%)
$110.28 M(+17.1%)
DateAnnualQuarterlyTTM
Dec 2018
$94.18 M(+32.1%)
$33.84 M(+33.4%)
$94.18 M(+25.0%)
Sep 2018
-
$25.37 M(+37.9%)
$75.31 M(+17.8%)
Jun 2018
-
$18.39 M(+10.9%)
$63.94 M(-7.4%)
Mar 2018
-
$16.58 M(+10.7%)
$69.08 M(-3.1%)
Dec 2017
$71.30 M(+38.2%)
$14.98 M(+7.1%)
$71.30 M(-0.4%)
Sep 2017
-
$13.99 M(-40.6%)
$71.62 M(+0.5%)
Jun 2017
-
$23.53 M(+25.2%)
$71.28 M(+20.8%)
Mar 2017
-
$18.80 M(+22.9%)
$59.00 M(+14.4%)
Dec 2016
$51.60 M(+43.1%)
$15.29 M(+12.1%)
$51.60 M(+9.1%)
Sep 2016
-
$13.64 M(+21.2%)
$47.27 M(+7.9%)
Jun 2016
-
$11.26 M(-1.2%)
$43.80 M(+5.9%)
Mar 2016
-
$11.40 M(+3.9%)
$41.35 M(+14.7%)
Dec 2015
$36.05 M(+105.2%)
$10.97 M(+7.9%)
$36.05 M(+15.3%)
Sep 2015
-
$10.17 M(+15.3%)
$31.26 M(+24.7%)
Jun 2015
-
$8.82 M(+44.8%)
$25.07 M(+23.9%)
Mar 2015
-
$6.09 M(-1.5%)
$20.23 M(+15.2%)
Dec 2014
$17.56 M(+135.3%)
$6.19 M(+55.5%)
$17.56 M(+26.6%)
Sep 2014
-
$3.98 M(+0.0%)
$13.88 M(+13.3%)
Jun 2014
-
$3.98 M(+16.3%)
$12.25 M(+48.1%)
Mar 2014
-
$3.42 M(+37.0%)
$8.27 M(+70.5%)
Dec 2013
$7.46 M(+35.0%)
$2.50 M(+6.0%)
$4.85 M(+106.0%)
Sep 2013
-
$2.35 M
$2.35 M
Dec 2012
$5.53 M
-
-

FAQ

  • What is Coherus BioSciences annual SGA?
  • What is the all time high annual SGA for Coherus BioSciences?
  • What is Coherus BioSciences annual SGA year-on-year change?
  • What is Coherus BioSciences quarterly SGA?
  • What is the all time high quarterly SGA for Coherus BioSciences?
  • What is Coherus BioSciences quarterly SGA year-on-year change?
  • What is Coherus BioSciences TTM SGA?
  • What is the all time high TTM SGA for Coherus BioSciences?
  • What is Coherus BioSciences TTM SGA year-on-year change?

What is Coherus BioSciences annual SGA?

The current annual SGA of CHRS is $192.01 M

What is the all time high annual SGA for Coherus BioSciences?

Coherus BioSciences all-time high annual SGA is $198.48 M

What is Coherus BioSciences annual SGA year-on-year change?

Over the past year, CHRS annual SGA has changed by -$6.47 M (-3.26%)

What is Coherus BioSciences quarterly SGA?

The current quarterly SGA of CHRS is $34.74 M

What is the all time high quarterly SGA for Coherus BioSciences?

Coherus BioSciences all-time high quarterly SGA is $56.53 M

What is Coherus BioSciences quarterly SGA year-on-year change?

Over the past year, CHRS quarterly SGA has changed by -$13.48 M (-27.95%)

What is Coherus BioSciences TTM SGA?

The current TTM SGA of CHRS is -$6.05 B

What is the all time high TTM SGA for Coherus BioSciences?

Coherus BioSciences all-time high TTM SGA is -$99.59 M

What is Coherus BioSciences TTM SGA year-on-year change?

Over the past year, CHRS TTM SGA has changed by -$6.24 B (-3182.44%)